influenza vaccine (Nventa)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinfluenza vaccine (Nventa)

Drug Alias Nameinfluenza vaccine (StressGen)Hsp65-influenza antigen fusion protein (StressGen)Hsp65-influenza antigen fusion protein (Nventa)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionHeat-shock protein modulators

TargetsHeat-shock protein

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNventa Biopharmaceuticals Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNventa Biopharmaceuticals Corp

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A